In the last two decades, there has been convincing documentation about the implication of endocan in several inflammatory and endothelial disorders, linked to pulmonary dysfunctions [4–6], cardiovascular events [7–9], kidney diseases [10–12], sepsis [13, 14], and cancer [15–17]. The gene discussed is ESM1; the disease is kidney disorder.